| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/08/2007 | WO2007026071A1 Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure |
| 03/08/2007 | WO2007025925A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007025901A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007025900A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| 03/08/2007 | WO2007025899A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007009395A8 Schisandrin b preparation |
| 03/08/2007 | WO2006134101A3 Use of pde1c and inhibitors thereof |
| 03/08/2007 | WO2006103401A3 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006042329A3 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 03/08/2007 | WO2006027579A3 The treatment of inflammatory disorders and pain |
| 03/08/2007 | US20070054951 Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053884 Novel adult tissue-derived stem cell and use thereof |
| 03/08/2007 | DE202006019784U1 Tee-Mischung Tea Mix |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620512A1 Compositons comprising phosphatidic acid for treatment of eosinophilia and related disorders |
| 03/08/2007 | CA2620466A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as .beta.2 adrenoceptor agonists |
| 03/08/2007 | CA2620129A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2620034A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619919A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619898A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619251A1 Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1759597A2 Antiallergic composition |
| 03/07/2007 | EP1758874A1 Substituted thiazoleacetic acids as crth2 ligands |
| 03/07/2007 | EP1758869A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 03/07/2007 | EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 03/07/2007 | EP1351704B1 Storage stable powder compositions of interleukin-4 receptor |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1255544B1 Mucin synthesis inhibitors |
| 03/07/2007 | EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof |
| 03/07/2007 | CN1925863A Extracts of scutellaria for the treatment of sars |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1925841A Pharmaceutical preparation for the oral cavity |
| 03/07/2007 | CN1923820A Novel carboxylic acid derivatives, their preparation and use |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923273A Nose-plug medicine for treating common cold and its preparing process |
| 03/07/2007 | CN1923268A Medicinal composition for treating rhinitis, its preparing method and quality controlling means |
| 03/07/2007 | CN1923258A Nose-plug medicine for treating acute nasal sinusitis and its preparing process |
| 03/07/2007 | CN1923242A Medicine for treating nasal cavity disease and preparation thereof |
| 03/07/2007 | CN1923232A Medicine composition for dispersing pathogenic wind and extinguishing phlegm, absorbing clots and softening hard masses, preparation method and use thereof |
| 03/07/2007 | CN1923210A Diructose anhydride-containing composition and use thereof |
| 03/07/2007 | CN1923187A Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 03/07/2007 | CN1923177A Chlorhydric acid tranditerol aerosol |
| 03/07/2007 | CN1922964A Planting and making process for American gold |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1303065C Ambroxol cysteine analogs salt and their preparation process and use thereof |
| 03/07/2007 | CN1302785C Health-care medicinal composition, and preparing method and use thereof |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186708 Steroidal compounds |
| 03/06/2007 | CA2277913C New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007024183A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
| 03/01/2007 | WO2007024182A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma. |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049639 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049570 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049550 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048321 Method for the treatment of fibrosis |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | CA2620847A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma. |
| 03/01/2007 | CA2620281A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
| 03/01/2007 | CA2620106A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620105A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757609A1 Novel water-soluble prodrug |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |